A Day Up For Bellicum Pharmaceuticals, Inc.

Thu 06 Feb 20 at 05:30 PM
A Day Up For Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) jumped higher at $10.28, representing a gain of 756.7%. On Wed 05 Feb 20, BLCM:NASDAQ touched a New 2-Week Low of $1.2. The stock got featured on our News Catalysts scanner on Wed 05 Feb 20 at 02:10 PM in the 'SPLIT' category. From Wed 15 Jan 20, the stock recorded 35.71% Up Days and 26.67% Green Days

The stock spiked on Fri 17 Jan 20 at $2.79 with a volume of 8M+.

About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)

Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.

Share